RUA.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 20:19):

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally...

Stats
Šios dienos apimtis	685 404
Vidutinė apimtis	654 251
Rinkos kapitalizacija	6.67M
EPS	£0 ( 2023-12-19 )
Kita pelno data	( £0 ) 2024-07-24
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.340
ATR14	£0.0810 (0.75%)

Rua Life Sciences PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Rua Life Sciences PLC Finansinės ataskaitos

Annual	2022
Pajamos:	£2.18M
Bruto pelnas:	£1.43M (65.76 %)
EPS:	£-0.0903

FY	2022
Pajamos:	£2.18M
Bruto pelnas:	£1.43M (65.76 %)
EPS:	£-0.0903

FY	2022
Pajamos:	£1.63M
Bruto pelnas:	£1.36M (83.57 %)
EPS:	£-0.0932

FY	2021
Pajamos:	£1.53M
Bruto pelnas:	£1.25M (81.94 %)
EPS:	£-0.0820

Financial Reports:

No articles found.

Rua Life Sciences PLC

RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.